NEW YORK – Life sciences distribution firm MyBio said Wednesday that it has signed an exclusive partnership with Qiagen to distribute the company's "Sample to Insight" life science research products in Ireland and Northern Ireland, beginning April 1.
The deal covers Qiagen's molecular analysis tools for biological samples including for sample collection; preparation; purification of DNA, RNA, and proteins; and identification and quantification. It does not extend to other Qiagen products such as IVD-regulated products, human identification and forensics, instrument services, or the Qiagen Digital Insights partner program. Financial terms of the agreement were not disclosed.
MyBio, based in Kilkenny, Ireland, said it will be targeting academic research, biopharma, and agri-bioscience companies.